Innovate With Regulators To Leverage DHT Data As Patient-Centric Primary Endpoints
Source: ActiGraph
This presentation explains how the FDA endorsed digital outcome measures of physical activity collected from ActiGraph technology as the primary endpoint in a pivotal cardiopulmonary trial, marking an important milestone for the industry.
Watch as Chief Executive Officer and Chief Regulatory of Safety and Quality Officer at Bellerophon Therapeutics Peter Fernandes discusses several case studies and strategies for using digital health technology to measure physical activity as the primary endpoint in clinical trials.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Tech Leader? Subscribe today.
Subscribe to Clinical Tech Leader
X
Subscribe to Clinical Tech Leader
ActiGraph
This website uses cookies to ensure you get the best experience on our website. Learn more